Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170,300.00 KRW | -1.90% |
|
-1.56% | -1.21% |
| 06-19 | South Korean Shares Snap Six-Day Winning Streak on Profit-Booking | MT |
| 06-18 | Celltrion's EU Clinical Trial Nod for Crohn's Disease Drug Lapses | MT |
| Market Cap | 37,425B 24.48B 21.33B 19.76B 18.49B 34.62B 2,307B 34.88B 234B 90.79B 1,136B 91.8B 89.86B 3,955B | P/E 2026 * |
28.7x | P/E 2027 * | 23.5x |
|---|---|---|---|---|---|
| Enterprise Value | 39.52B 25.85M 22.53M 20.87M 19.52M 36.55M 2.44B 36.83M 247M 95.87M 1.2B 96.94M 94.88M 4.18B | EV / Sales 2026 * |
7.42x | EV / Sales 2027 * | 6.27x |
| Free-Float |
53.67% | Yield 2026 * |
0.44% | Yield 2027 * | 0.47% |
| 1 day | -1.90% | ||
| 1 week | -1.56% | ||
| Current month | -7.30% | ||
| 1 month | -0.33% | ||
| 3 months | -11.48% | ||
| 6 months | -3.08% | ||
| Current year | -1.21% |
| 1 week | 166,500 |  | 177,800 |
| 1 month | 158,500 | | 192,380.95 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 150,857.14 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 61,908.65 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 50 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-15 | Sell | 500 | 0.0002% | |||
| 01-15 | Sell | 1,000 | 0.0004% | |||
| 01-15 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | -1.56% | +10.24% | +21.21% | 24.45B | |
| +1.44% | +1.71% | -10.98% | -6.19% | 43.13B | |
| +3.31% | +5.93% | +310.97% | +534.70% | 34.65B | |
| +2.84% | +2.14% | +9.34% | +41.02% | 30.03B | |
| -1.70% | -7.54% | +8.43% | -21.94% | 28B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +48.76% | +104.27% | 13.14B | |
| -0.57% | -2.43% | +5.08% | +4.79% | 12.53B | |
| -0.26% | +1.15% | +98.13% | +80.47% | 12.25B | |
| +1.91% | -0.12% | -0.33% | -36.60% | 11.18B | |
| Average | +0.56% | +0.40% | +53.29% | +80.19% | 22.37B | |
| Weighted average by Cap. | +0.83% | +1.08% | +61.96% | +102.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,324B 3.48B 3.03B 2.81B 2.63B 4.93B 328B 4.96B 33.34B 12.92B 162B 13.06B 12.78B 563B | 6,171B 4.04B 3.52B 3.26B 3.05B 5.71B 380B 5.75B 38.64B 14.97B 187B 15.14B 14.82B 652B |
| Net income | 1,397B 914M 796M 738M 690M 1.29B 86.13B 1.3B 8.75B 3.39B 42.4B 3.43B 3.35B 148B | 1,687B 1.1B 962M 891M 833M 1.56B 104B 1.57B 10.56B 4.09B 51.2B 4.14B 4.05B 178B |
| Net Debt | 2,093B 1.37B 1.19B 1.11B 1.03B 1.94B 129B 1.95B 13.11B 5.08B 63.52B 5.13B 5.03B 221B | 1,267B 829M 722M 669M 626M 1.17B 78.09B 1.18B 7.93B 3.07B 38.45B 3.11B 3.04B 134B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 170,300.00 ₩ | -1.90% | 1,160,752 |
| 26-06-18 | 173,600.00 ₩ | -0.57% | 443,187 |
| 26-06-17 | 174,600.00 ₩ | +0.06% | 500,727 |
| 26-06-16 | 174,500.00 ₩ | -0.29% | 427,814 |
| 26-06-15 | 175,000.00 ₩ | +1.16% | 400,596 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
